Carotid Artery Disease



Carotid Artery Disease


Hemal Gada



I. EPIDEMIOLOGY AND ETIOLOGY OF STROKE

A. Annually, there are nearly 800,000 strokes in the United States and 15 million strokes worldwide. Stroke is the third leading cause of death in Western societies and the leading cause of long-term disability in the United States.

B. Ischemic stroke accounts for approximately 85% of all strokes and can be classified into two broad categories.

1. Embolic: May be arterial (e.g., aortic atheroma or large vessel atherosclerosis in the carotid, vertebral, or basilar arteries) or cardiac (e.g., left ventricular thrombus postmyocardial infarction [post-MI], atrial fibrillation, valvular disorders, and cardiac tumors) in origin and most often occurs suddenly, with deficits indicating focal loss of brain function.

2. Thrombotic: May be caused by stenosis of smaller intracerebral arteries, a hyper-coagulable state, or a systemic inflammatory condition causing vasculitis, with symptoms that may fluctuate in presence and intensity.


II. NORMAL CAROTID ANATOMY

A. The aortic arch normally gives rise to the innominate artery (aka brachiocephalic artery), the left common carotid artery (CCA), and the left subclavian artery (Fig. 28.1). The innominate artery bifurcates into the right CCA and the right subclavian artery. The left common carotid arises from the aortic arch in 70% of people and from the innominate artery in 20% (“bovine arch” variant).







FIGURE 28.1 Normal anatomy of the aortic arch, great vessels, and circle of Willis. The shaded regions depict the areas most prone for the development of atherosclerosis.

B. The aortic arch can be classified into three types based on the distance of the origin of the great vessels from the top of the arch (Fig. 28.2). The widest diameter of the left common carotid is used as a reference unit. If all the great vessels originate within an arc of the aortic arch subtended by a line parallel to a horizontal reference line at the top of the arch and separated from the top reference line by the reference unit, it is classified as a type I arch. In a type II arch, all the great vessels originate within an arc within two reference units from the top of the arch, and in a type III arch the great vessels originate within an arc beyond two reference units from the top of the arch. Type III arches are harder to access during percutaneous intervention than type I arches.

C. The CCAs divide into the internal and external carotids at the C4-5 level in 50% of the patients. In approximately 40% of patients, the bifurcation is higher, and it is lower in the remaining 10%.

D. The external carotid artery provides flow to the facial muscles, scalp, and thyroid. It has a complex system of collaterals, and symptoms from stenosis are rare.

E. The circle of Willis provides collateral flow between the left and right hemispheres of the brain and connects the anterior and posterior circulation.


III. RISK FACTORS FOR CAROTID ATHEROSCLEROSIS


A. Smoking and age

are the two most important risk factors for developing carotid atherosclerosis. The others, in order of importance, are hypertension, diabetes, gender (men more than women if younger than 75 years; women more than men if older than 75 years), and hyperlipidemia. As with coronary artery disease (CAD), inflammation likely plays a major role in carotid disease. African American men and Hispanic Americans appear to have a higher incidence of carotid atherosclerosis. Some data suggest a role for chronic infection in the development of carotid disease.







FIGURE 28.2 Aortic arch classification. The classification system is based on the distance of the origin of the great vessels from the top of the arch.


B. Elevated serum lipoprotein(a) has been associated with intracranial, extracranial, and aortic large artery occlusive disease.

C. Between 30% and 60% of patients with peripheral arterial disease have carotid disease, and approximately 50% to 60% of patients with carotid disease have severe CAD. However, only 10% of patients with CAD have severe carotid disease.


IV. PATHOPHYSIOLOGY

A. As with coronary disease, atherosclerotic carotid disease usually develops at branch points and bends, especially at the bifurcation of the CCA and origin of the internal carotid artery (ICA) (Fig. 28.1).

B. Plaque is most often localized at the carotid bifurcation and tends to extend from the outer wall of the carotid bulb into the ICA origin (Fig. 28.1).

C. The reasons that carotid stenoses become symptomatic are not completely understood, but there is a linear increase in the risk of stroke as the stenosis increases to > 70%. Two hypotheses explain how carotid disease can cause stroke.

1. Carotid plaque is highly vascularized. Rupture of this vasculature or rupture of the plaque can result in plaque hemorrhage or ulceration, with subsequent in situ thrombus formation. This can lead to complete vessel obstruction or distal atherothromboembolism. This mechanism accounts for most cerebrovascular events caused by carotid disease.

2. Larger plaques can result in high-grade carotid stenosis or obstruction, with subsequent ischemic stroke due to a reduction in cerebral flow, in the setting of inadequate or absent collateral circulation.




VI. MANAGEMENT OF CAROTID DISEASE


A. Medical management


1. Risk factor modification.

Aggressive cardiovascular risk factor modification is recommended to reduce the risk of stroke and prevent the progression of existing disease, regardless of whether or not revascularization is indicated. Smoking cessation, blood pressure control to levels recommended by the Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure (JNC7) guidelines (< 140/90 mm Hg and more aggressive control in patients with atherosclerotic cardiovascular disease,
chronic kidney disease, or diabetes), control of diabetes (HbA1c < 7%), and lipid management (goal low-density lipoprotein [LDL] < 100 mg/dL, < 70 mg/dL if high CAD risk) are important treatment goals for which to strive in any patient with carotid disease.


2. Antiplatelet therapy

a. The Antiplatelet Trialists’ meta-analysis including 73,247 high-risk patients found that antiplatelet therapy as secondary prevention resulted in a 27% (25% attributed to aspirin) relative reduction in the combined end point of vascular death, MI, and stroke.

Jun 7, 2016 | Posted by in CARDIOLOGY | Comments Off on Carotid Artery Disease

Full access? Get Clinical Tree

Get Clinical Tree app for offline access